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A few cases of a gastrointestinal stromal tumor (GIST) of the small intestine presenting as rupture have been reported
in the medical literature. We report an unusual case of a large GIST of the jejunum that presented as a spontaneous
rupture. A 70-year-old man was referred to our hospital because of fever and abdominal pain. An abdominal enhanced
computed tomography (CT) scan detected a 10-cm tumor with heterogeneous staining, suggesting necrosis or abscess
inside the tumor. The patient was treated with antibiotics but inflammation persisted and an operation was performed.
Intraoperative findings showed an outgrowing 10-cm mass in the jejunum near Treitz's ligament. The tumor had
ruptured with peritoneal metastasis. The solid parenchyma contained a focal area of necrosis within and the small
ulcer located in the wall of the jejunum presented a communication with the large tumor cavity. H&E staining showed
spindle-shaped cell proliferation, and immunohistochemical staining showed results positive for c-kit and CD34. The
patient received a diagnosis of a GIST (high-risk group) of the jejunum and was treated with imatinib mesylate. The
patient has remained in good health without recurrence or metastasis one year after the surgical procedure.Background
Gastrointestinal stromal tumors (GISTs) are the most
common mesenchymal tumor of the gastrointestinal
tract [1]. Most GISTs are > 5 cm in diameter at the time
of diagnosis, with a diameter of 10 cm being associated
with a higher risk of local or distant metastasis. In
addition to tumor size, mitotic rate and tumor location,
tumor rupture is thought to be a prognostic factor for
the outcome of patients with a GIST. Gastrointestinal
bleeding is the most common presentation (50%) of
GISTs and is usually associated with ulceration of the
tumor into the lumen [2,3]. We report an unusual case
of a large GIST of the jejunum that presented as spon-
taneous rupture.
Case presentation
A 70-year-old man presented with symptoms of fever and
abdominal pain. There were no episodes of gastrointes-
tinal bleeding. The blood pressure was 117/86 mmHg, the
pulse 80 beats per minute, and the temperature 38.2°C.* Correspondence: 96084sm@jichi.ac.jp
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unless otherwise stated.Abdominal examination revealed tenderness and muscular
defense in the left upper quadrant, and rectal examination
revealed an empty ampulla. Blood tests showed a
hemoglobin level of 7.2 g/dL, white blood cell count of
25,490/mm3, and C-reactive protein of 19 mg/dL. An
abdominal enhanced computed tomography (CT) scan
revealed a 10 × 10-cm solid tumor with a low-density area
within, suggesting necrosis or abscess; additionally, a liver
metastasis was suspected (Figure 1). Upper GI endoscopy
revealed no aberrations up to the third portion of the duo-
denum. Examination of small bowel x-ray series revealed
no tumor penetration. The mass was suspected as a GIST
of the jejunum accompanied by a giant abscess. The pa-
tient was treated with intravenous administration of antibi-
otics and blood transfusion. Subsequent to improvement
in his clinical condition and laboratory tests, laparotomy
was performed. Intraoperative findings showed mild ascites
but there was no blood in the abdominal cavity. We also
found an outgrowing 10-cm mass in the jejunum near
Treitz’s ligament. The tumor was ruptured and peritoneal
metastasis was detected around the tumor. Segmental
resection of the jejunum with the tumor was performed.
The resected mass was a well-circumscribed tumorLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 An abdominal enhanced computed tomography scan,
revealing a 10 × 10-cm solid tumor with low-density area
within, suggesting necrosis or abscess.
Figure 3 H&E staining showed spindle-shaped cell proliferation.
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solid parenchyma contained central necrosis with a fistula
to the lumen of the jejunum (Figure 2). H&E staining
showed spindle-shaped cell proliferation (Figure 3), and
immunohistochemical staining showed positive results for
c-kit (Figure 4) and CD34 (Figure 5), and a nuclear expres-
sion of the proliferation-associated Ki-67-antigen in appro
ximately 26% of the tumor cells (Figure 6). GIST (high-risk
group) of the jejunum was diagnosed and treated with ima-
tinib mesylate, 400 mg daily, after the 21st post-operative
day. The patient was discharged after endoscopic dilationFigure 2 The solid parenchyma contained central necrosis with
a fistula to the lumen of the jejunum.for an anastomotic stricture. Medical treatment was con-
tinued and the patient was followed up with an abdominal
CT scan 12 months after the surgical procedure without
any signs of recurrence.
Discussion
GISTs are visceral tumors arising from any site of the
gastrointestinal tract. Approximately 60 to 70% of cases
occur in the stomach, 25 to 35% in the small intestine,
and 10% in the jejunum, whereas the esophagus, colon,
rectum, and appendix, are rarely affected [4]. Bleeding (30
to 40% of cases) comprises the most common symptom
after vague abdominal discomfort. Patients with GIST of
the jejunum usually suffer from abdominal pain or have a
palpable mass, and also complain of early satiety and ab-
dominal fullness. Pressure necrosis and ulceration of the
overlying mucosa may cause gastrointestinal bleeding, and
patients who experience a significant blood loss may suffer
from malaise and fatigue. Bleeding into the lumen of theFigure 4 Immunohistochemical staining showed positive results
for c-kit.
Figure 5 Immunohistochemical staining showed positive results
for CD34.
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http://www.wjso.com/content/12/1/153GI tract, causing hematemesis, melena, or anemia, is usu-
ally more chronic on presentation [5]. Obstruction may
result from intraluminal growth of the tumor or luminal
compression from an exophytic lesion. Fever, anorexia,
and weight loss are rarely observed, and GISTs originating
in the jejunum seldom cause perforation and acute diffuse
peritonitis. A few cases have been reported in the English
medical literature associated with perforation or rupture
of GIST in the small intestine [6-16] (Table 1). Bleeding
into the peritoneal cavity due to a ruptured GIST can lead
to acute abdominal pain presenting as a surgical emer-
gency [6,7,10,12,16]. In addition, only a few cases of GIST
of the small intestine accompanied with abscess formation
have been reported [9,14]. In this case, GIST originating
in the jejunum was invaded via a fistula, leading to central
necrosis and spontaneous rupture into the peritoneal cav-
ity. For GISTs, prognostic markers that include tumorFigure 6 Nuclear expression of the proliferation-associated
Ki-67-antigen in approximately 26% of the tumor cells.size > 5 cm, mitotic rate > 5/50 high-power fields (HPF),
tumor necrosis, and a Ki-67(MIB-1) index of > 10% are all
associated with malignancy of the tumor and high mortal-
ity [17-19]. GISTs can be categorized as low or high risk
tumors by taking into account the possibility of metastasis
or recurrence. However, the main prognostic factor is the
mitotic count. A prognostic classification was defined by
Fletcher et al. and is widely accepted and used today
[17-19] (Table 2). In contrast, the MIB-1 index (>22% in
the most active area) was the most powerful predictor of
poor survival [20]. The prognosis is dismal when the
tumor presents with symptoms or signs such as perfor-
ation or rupture, multifocal location, or metastatic lesions.
Patients with localized or locally advanced tumors have
46% 5-year survival, except for patients with a metastatic
or multifocal tumor. Those patients have 5-year survival
at 24%, probably because of peritoneal dissemination [21].
The introduction of imatinib mesylate, a tyrosine kinase
inhibitor targeting KIT has provided a much needed che-
motherapeutic option for patients with both resectable
and unresectable GISTs. Despite the noted success of ima-
tinib, surgical resection is the main treatment modality for
primary GIST of any localization [22,23]. Imatinib treat-
ment of GISTs is a dynamic process with the permanent
risk of pharmacoresistance and maximal response within
the first six months of therapy [24]. Futhermore, the
patients with a primary GIST treated for spontaneous rup-
ture or with rupture occurring during resection have a
very high risk of tumor recurrence. These patients are
candidates for adjuvant treatment with imatinib [25]. Our
case is classified as high-risk GIST with poor prognosis
and medical treatment was continued with imatinib; how-
ever, no signs of recurrence were observed with abdominal
CT scan 12 months after the surgery.Conclusion
In conclusion, spontaneous rupture is a rare presentation
of GIST and preoperative diagnosis is difficult because of
the absence of pathognomonic signs or symptoms. The
diagnosis should be suspected whenever there is a presen-
tation of fever and abdominal pain in patients with an
intraabdominal mass. In this case, GIST originating in the
jejunum led to central necrosis and spontaneous rupture
in the peritoneal cavity; however, local excision of the
tumor associated with adjuvant therapy with imatinib
mesylate was effective and these treatments remain the
main modality of treatment of high-risk GISTs.Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.
Table 1 Summary of spontaneous ruptured gastrointestinal stromal tumor (GIST) of small intestine in the english medical literature
Author
(reference)













1 Ajduck M [6] 2004 60 F jejunum abdominal
pain
laparotomy + - - 3/50HPF 7.5 SR N/A
2 Cegarra-
NavarroMF [7]
2005 76 M jejunum abdominal
pain
CT + - - < 5/50HPF 6 SR 31 months
ANED
3 Efremidou EI [8] 2006 66 M ileum abdominal
pain




4 Karagülle E [9] 2008 70 M jejunum abdominal
pain
CT - + - 0/50HPF 5 SR 13 months
ANED
5 Hirasaki S [10] 2008 87 F ileum abdominal
pain
CT + - - N/A 13 × 11 SR 16 months
ANED
6 Ku MC [11] 2010 33 F jejunum abdominal
pain
CT - - + N/A 6.5 ×
5.3 × 3.9
SR N/A
7 Varras M [12] 2010 28 F N/A abdominal
pain
US + - - > 5/50HPF 13 SR 3 years
ANED
8 Feng F [13] 2011 45 M jejunum abdominal
pain
CT - - - < 5/50HPF 10 × 8 SR N/A
9 Chen HW [14] 2011 22 M jejunum abdominal
pain
CT - + - N/A 5 SR 2 months
ANED
10 Memmi N [15] 2012 59 M jejunum abdominal
pain
CT - - - 7/50HPF 12 SR N/A
11 Nannini M [16] 2013 45 F jejunum abdominal
pain




12 This case 2014 71 M jejunum abdominal
pain fever

























Table 2 Prognostic classification of gastrointestinal
stromal tumors (GISTs) by Fletcher et al. [17]
Risk of malignancy Size of tumor (cm) Mitotic counts (/50HPF)
Very low < 2 < 5
Low 2 to 5 < 5
Intermediate < 5 6 to 10
5 to 10 < 5
High > 5 > 5
> 10 Any counts
Any size > 10
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